<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0871643A1" file="EP96930490NWA1.xml" lang="en" doc-number="0871643" date-publ="19981021" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI..........................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0871643</B110><B130>A1</B130><B140><date>19981021</date></B140><B190>EP</B190></B100><B200><B210>96930490.0</B210><B220><date>19960717</date></B220><B240><B241><date>19980216</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>19950001505</B310><B320><date>19950719</date></B320><B330><ctry>US</ctry></B330><B310>19950535168</B310><B320><date>19951023</date></B320><B330><ctry>US</ctry></B330><B310>19960013688</B310><B320><date>19960319</date></B320><B330><ctry>US</ctry></B330><B310>19960014007</B310><B320><date>19960325</date></B320><B330><ctry>US</ctry></B330><B310>19960016271</B310><B320><date>19960423</date></B320><B330><ctry>US</ctry></B330><B310>19960015714</B310><B320><date>19960417</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>19981021</date><bnum>199843</bnum></B405><B430><date>19981021</date><bnum>199843</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07H  21/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>C12N  15/   113            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  38/    00            A N                    </text></classification-ipcr></B510EP><B540><B541>en</B541><B542>ANTI-VIRAL GUANOSINE-RICH OLIGONUCLEOTIDES</B542><B541>fr</B541><B542>OLIGONUCLEOTIDES ANTIVIRAUX RICHES EN GUANOSINE</B542><B541>de</B541><B542>ANTIVIRALE GUANOSINEREICHE OLIGONUKLEOTIDE</B542></B540></B500><B700><B710><B711><snm>Aronex Pharmaceuticals, Inc.</snm><adr><str>3400 Research Forest Drive</str><city>The Woodlands, TX 77381</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>RANDO, Robert, F.</snm><adr><str>35 Dovetail Place</str><city>The Woodlands, TX 77380</city><ctry>US</ctry></adr></B721><B721><snm>FENNEWALD, Susan</snm><adr><str>3500 Tanglebrush Drive  187</str><city>The Woodlands, TX 77381</city><ctry>US</ctry></adr></B721><B721><snm>ZENDEGUI, Joseph, G.</snm><adr><str>11425 Slash Pine Place</str><city>The Woodlands, TX 77380</city><ctry>US</ctry></adr></B721><B721><snm>OJWANG, Joshua, O.</snm><adr><str>2218 Fincher Creek Drive</str><city>Spring, TX 77386</city><ctry>US</ctry></adr></B721><B721><snm>HOGAN, Michael, E.</snm><adr><str>103 Golden Shadow Circle</str><city>The Woodlands, TX 77381</city><ctry>US</ctry></adr></B721><B721><snm>POMMIER, Yves, Lab. of Molecular Pharmacology</snm><adr><str>Nat.Cancer Institute, National Institute of Health</str><city>Bethesda, MD 20892</city><ctry>US</ctry></adr></B721><B721><snm>MAZUMDER, Abhijit, Lab. of Molecular Pharmacology</snm><adr><str>National Cancer Institute</str><city>Bethesda, MD 20892 0892</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Wise, Stephen James, et al</snm><adr><str>c/o RAWORTH, MOSS &amp; COOK 36 Sydenham Road</str><city>Croydon, Surrey CR0 2EF</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>US1996011786</anum></dnum><date>19960717</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1997003997</pnum></dnum><date>19970206</date><bnum>199707</bnum></B871></B870></B800></SDOBI></ep-patent-document>